Related Experiment Video
Updated: Nov 6, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Systemic immune inflammation index: a novel predictor for coronary collateral circulation
Saban Kelesoglu1, Yucel Yilmaz2, Deniz Elcık1
1Department of Cardiology, Erciyes University Faculty of Medicine, Kayseri, Turkey.
Insights
The Systemic Immune Inflammation Index (SII) is a new marker that predicts poor Coronary Collateral Circulation (CCC) in stable Coronary Artery Disease (CAD) patients. Higher SII levels indicate a greater likelihood of developing inadequate CCC.
Area of Science:
- Cardiology
- Inflammation Markers
- Vascular Biology
Background:
- Coronary Artery Disease (CAD) is a leading cause of mortality worldwide.
- Coronary Collateral Circulation (CCC) plays a crucial role in mitigating ischemic damage in CAD.
- Identifying reliable markers for predicting CCC development is essential for patient management.
Purpose of the Study:
- To investigate the association between the Systemic Immune Inflammation Index (SII) and the formation of CCC in patients with stable CAD.
- To evaluate SII as a potential predictor of inadequate CCC development.
Main Methods:
- A cohort of 449 patients with stable CAD and significant coronary stenosis was analyzed.
- Patients were categorized based on CCC status using the Rentrop score (well CCC: Rentrop 2-3; bad CCC: Rentrop 0-1).
- The Systemic Immune Inflammation Index (SII) was calculated as platelet count × neutrophil/lymphocyte count.
Main Results:
- Patients with inadequate CCC exhibited significantly higher levels of C-reactive protein (CRP), neutrophil/lymphocyte ratio (NLR), platelets/lymphocyte ratio (PLR), and SII compared to those with well-developed CCC (p < 0.001).
- Multivariate logistic regression identified high SII levels as an independent predictor of inadequate CCC (OR: 1.005, 95% CI: 1.003-1.006, p < 0.001).
- Receiver Operator Characteristic (ROC) analysis determined an optimal SII cutoff of 729.8 for predicting poor CCC, with 78.4% sensitivity and 74.6% specificity (AUC = 0.833).
Conclusions:
- The Systemic Immune Inflammation Index (SII) is a novel and independent predictor of Coronary Collateral Circulation (CCC) development in stable Coronary Artery Disease (CAD).
- SII may serve as a valuable prognostic marker in assessing the potential for collateralization in CAD patients.
- Further research is warranted to explore the clinical utility of SII in cardiovascular risk stratification.
Aim:
Recently, a new inflammatory and prognostic marker has emerged called as Systemic Immune Inflammation Index (SII). In the current study, we searched the relation between SII and Coronary Collateral Circulation (CCC) formation in stable Coronary Artery Disease (CAD).
Materials & Methods:
449 patients with stable CAD who underwent coronary angiography and documented coronary stenosis of 95% or more in at least one major coronary vessel were included in the study. The study patients were divided into two groups according to the Rentrop score as well CCC (Rentrop 2-3) and bad CCC (Rentrop 0-1). Blood samples for SII and other laboratory parameters were gathered from all the patients on admission. The SII score was formulized as platelet × neutrophil/lymphocyte counts.
Results:
Patients, who had developed bad CCC had a higher C-reactive protein (CRP), neutrophil/lymphocyte ratio (NLR), platelets/lymphocyte ratio (PLR) and SII levels compared to those who had developed well CCC (p < 0.001, for all). Multivariate logistic regression analysis showed that high levels of SII was an independent predictor of bad CCC (OR: 1.005, 95% confidence interval (CI): 1.003-1.006, p < 0.001) together with dyslipidemia, high levels of CRP and NLR. In Receiver Operator Characteristic curve (ROC) analysis, the optimal cutoff value of SII to predict poor CCC was found to be 729.8, with 78.4% sensitivity and 74.6% specificity (area under ROC curve = 0.833 (95% CI: 0.777-0.889, p < 0.001).
Conclusion:
We have demonstrated that SII, a novel cardiovascular risk marker, might be used as one of the independent predictors of CCC development.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Myocarditis I: Introduction
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis II: Clinical Features and Diagnostic Tests